Clozapine and risk of pneumonia

British Journal of Psychiatry

Volumn 194, Issue 5, 2009, Pages 468-469

  Abdelmawla, Nasser ^a   Ahmed, Magdi I ^a  

^a Northamptonshire Healthcare NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLOZAPINE; CYTOCHROME P450 1A2; CYTOKINE; NEUROLEPTIC AGENT;

AGRANULOCYTOSIS; APOPTOSIS; ASPIRATION PNEUMONIA; BRONCHITIS; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG FATALITY; DRUG WITHDRAWAL; DYSPHAGIA; ESOPHAGUS DILATATION; FLUENCY DISORDER; HUMAN; HYPERSALIVATION; INFECTION; INFECTION RISK; INFLAMMATION; LETTER; LIVER MICROSOME METABOLISM; MYOCLONUS; NEUTROPENIA; PNEUMONIA; RISK FACTOR; SEDATION; SIDE EFFECT; TIME OF DEATH; CHEMICALLY INDUCED;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; PNEUMONIA;

EID: 67649349628     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.194.5.468a     Document Type: Letter

References (6)

1. Taylor DM, Douglas-Hall P. Olofinjana B, Whiskey E, Thomas A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry 2009; 194: 165-7.
2. Hinkes R, Quesada TV, Currier MB, Gonzalez-Blanco M. Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea. J clin Pharmacol 1996; 16: 462-3.
3. Maddalena AS. Fox M, Hofmann M, Hock C. Esophageal dysfunction on psychotropic medication. A case report and literature review. Pharmacopsychiatry 2004; 37: 134-8.
4. Haack MJ, Bak ML, Beurskens R, Maes M, Stolk LM, Delespaul PA. Toxic rise of clozapine plasma concentrations in relation to inflammation. Euro Neuropsychopharmacol 2003; 13: 381-5.
5. Raaska K, Raitasuo V, Arstila M. Neuvonen PJ. Bacterial pneumonia can increase serum concentration of clozapine. Euro J Clin Pharmacol 2002; 58: 321-2.
6. De Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1059-63.